Evidence map›Paper›PMID 34252116›Full record

ArticlePloS one2021

A novel high-throughput screen for identifying lipids that stabilise membrane proteins in detergent based solution.

Cristina Cecchetti, Jannik Strauss, Claudia Stohrer, Claire Naylor, Edward Pryor, Jeanette Hobbs, Simon Tanley, Adrian Goldman, Bernadette Byrne

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Detergents alter the stability and lipid binding properties of the CD1d immunoreceptor.Protein science : a publication of the Protein Society · 2026
    Article
  2. Design of a water-soluble CD20 antigen with computational epitope scaffolding.Protein science : a publication of the Protein Society · 2025
    Article
  3. Article
  4. Article
  5. Discovery of Therapeutic Antibodies Targeting Complex Multi-Spanning Membrane Proteins.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Over-Production of the Human SLC7A10 inInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The high-throughput production of membrane proteins.Emerging topics in life sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Cristina CecchettiDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Jannik StraussAstbury Centre for Structural and Molecular Biology, University of Leeds, Leeds, United Kingdom.
Claudia StohrerAstbury Centre for Structural and Molecular Biology, University of Leeds, Leeds, United Kingdom.
Claire NaylorMolecular Dimensions, Sheffield, United Kingdom.
Edward PryorAnatrace, Maumee, Ohio, United States of America.ORCID 0000-0001-8328-9126
Jeanette HobbsMolecular Dimensions, Sheffield, United Kingdom.
Simon TanleyMolecular Dimensions, Sheffield, United Kingdom.
Adrian GoldmanAstbury Centre for Structural and Molecular Biology, University of Leeds, Leeds, United Kingdom.
Bernadette ByrneDepartment of Life Sciences, Imperial College London, London, United Kingdom.ORCID 0000-0001-9598-9832
Molecular DimensionsUniversity of Leeds · GBImperial College London · GBAnatrace · US

Funding

Biotechnology and Biological Sciences Research Council BB/N016467/1Biotechnology and Biological Sciences Research Council BB/T006048/1
6 · The paper itself

Abstract

Membrane proteins have a range of crucial biological functions and are the target of about 60% of all prescribed drugs. For most studies, they need to be extracted out of the lipid-bilayer, e.g. by detergent solubilisation, leading to the loss of native lipids, which may disturb important protein-lipid/bilayer interactions and thus functional and structural integrity. Relipidation of membrane proteins has proven extremely successful for studying challenging targets, but the identification of suitable lipids can be expensive and laborious. Therefore, we developed a screen to aid the high-throughput identification of beneficial lipids. The screen covers a large lipid space and was designed to be suitable for a range of stability assessment methods. Here, we demonstrate its use as a tool for identifying stabilising lipids for three membrane proteins: a bacterial pyrophosphatase (Tm-PPase), a fungal purine transporter (UapA) and a human GPCR (A2AR). A2AR is stabilised by cholesteryl hemisuccinate, a lipid well known to stabilise GPCRs, validating the approach. Additionally, our screen also identified a range of new lipids which stabilised our test proteins, providing a starting point for further investigation and demonstrating its value as a novel tool for membrane protein research. The pre-dispensed screen will be made commercially available to the scientific community in future and has a number of potential applications in the field.

Indexed as

DetergentsHigh-Throughput Screening AssaysHumansLipidsMembrane ProteinsNanoparticlesProtein StabilitySolutionsDetergentsLipidsMembrane ProteinsSolutions

Identifiers

PMID34252116
PMCPMC8274869
OpenAlexW3182500974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.